Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Pringy: medical device reports filed with FDA

2,564 reports name it as the manufacturer of the device involved, 2008–2026.

2,564
reports naming it as manufacturer
0% of all MAUDE reports
1,352
reports, 12 months to August 2026
885 in the 12 months before
0.2%
classified as malfunction
62.3% across all reports
0.1%
classified as death, as reported
0.9% across all reports

2,564 medical device reports received by FDA give Pringy as the manufacturer of the device involved, 0% of the MAUDE database, from May 2008 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

1,352 reports arrived in the 12 months to August 2026, up 53% from 885 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (99.6%), malfunction (0.2%) and other (0.1%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Juvederm Voluma Xc/Lido Volume UnknownImplant, dermal, for aesthetic use3051940.1%
Unk Juvederm VoluxImplant, dermal, for aesthetic use2451330%
Unk VolbellaImplant, dermal, for aesthetic use147700%
Juvederm Voluma XC 27G 2 x 1mLImplant, dermal, for aesthetic use142780%
SKINVIVE by JUVEDERM XC 2x1 mLImplant, dermal, for aesthetic use1401060.4%
Unk Juvederm VoliteImplant, dermal, for aesthetic use112540%
Volift Volume UnknownImplant, dermal, for aesthetic use105520.3%
Juv Derm Voluma With LidocaineImplant, dermal, for aesthetic use92500%
Juvederm Volume/Concentration/Additive UnknownImplant, dermal, for aesthetic use68240.6%
JUVEDERM Volift w/Lido 2x1mL EAME SKU1Implant, dermal, for aesthetic use56220%
Vollure Volume UnknownImplant, dermal, for aesthetic use53280%
JUVEDERM VOLBELLA XC 2 x 1mL 32GImplant, dermal, for aesthetic use48270%
Juvederm VOLUMA WITH LIDOCAINE 1mLImplant, dermal, for aesthetic use37230%
JUVEDERM VOLLURE XC 2x1 mLImplant, dermal, for aesthetic use34240.5%
Juvederm Voluma Volume/Additive UnknownImplant, dermal, for aesthetic use25130%
Juvederm Ultra Plus Xc Tsk UsImplant, dermal, for aesthetic use1950%
UNK Dermal FillerImplant, dermal, for aesthetic use19250.5%
VOLIFT with LIDOCAINEImplant, dermal, for aesthetic use14100%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
LMHImplant, dermal, for aesthetic use2,564100%

Reports by month, five years

096192Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 4Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 1Aug 2022: 0Sep 2022: 0Oct 2022: 1Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 1Oct 2023: 0Nov 2023: 8Dec 2023: 252024Jan 2024: 16Feb 2024: 4Mar 2024: 13Apr 2024: 39May 2024: 58Jun 2024: 24Jul 2024: 30Aug 2024: 31Sep 2024: 59Oct 2024: 68Nov 2024: 76Dec 2024: 602025Jan 2025: 69Feb 2025: 72Mar 2025: 79Apr 2025: 90May 2025: 76Jun 2025: 71Jul 2025: 103Aug 2025: 62Sep 2025: 72Oct 2025: 109Nov 2025: 96Dec 2025: 982026Jan 2026: 80Feb 2026: 117Mar 2026: 112Apr 2026: 113May 2026: 105Jun 2026: 133Jul 2026: 192Aug 2026: 125

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death0.1%2
Injury99.6%2,553
Malfunction0.2%6
Other0.1%3
Not given0%0

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Pringy reports

How many FDA device reports name Pringy as manufacturer?

2,564 reports through August 2026, 1,352 of them in the latest 12 months.

Which of its brands appear most often?

Juvederm Voluma Xc/Lido Volume Unknown (305), Unk Juvederm Volux (245), Unk Volbella (147), Juvederm Voluma XC 27G 2 x 1mL (142) and SKINVIVE by JUVEDERM XC 2x1 mL (140).

Which device types does it report on?

implant, dermal, for aesthetic use (100%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.